-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Pure Bioscience, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2011 to 2024.
- Pure Bioscience, Inc. Nonoperating Income (Expense) for the quarter ending July 31, 2024 was -$57K, a 613% decline year-over-year.
- Pure Bioscience, Inc. Nonoperating Income (Expense) for the twelve months ending July 31, 2024 was -$159K, a 783% decline year-over-year.
- Pure Bioscience, Inc. annual Nonoperating Income (Expense) for 2024 was -$159K, a 783% decline from 2023.
- Pure Bioscience, Inc. annual Nonoperating Income (Expense) for 2023 was -$18K, a 108% decline from 2022.
- Pure Bioscience, Inc. annual Nonoperating Income (Expense) for 2022 was $233K.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)